Upregulation of microRNA-520a-3p inhibits the proliferation, migration and invasion via spindle and kinetochore associated 2 in gastric cancer
- PMID: 31452811
- PMCID: PMC6704319
- DOI: 10.3892/ol.2019.10663
Upregulation of microRNA-520a-3p inhibits the proliferation, migration and invasion via spindle and kinetochore associated 2 in gastric cancer
Abstract
MicroRNAs (miR) serve important roles in the development and progression of tumors by targeting different genes. miR-520a-3p reported in lung and breast cancers as a tumor suppressor gene. However, the expression and functional significance of miR-520a-3p is not completely understood in gastric cancer (GC). In the present study, it was demonstrated that the expression levels of miR-520a-3p were significantly downregulated in GC tissues and cells using RT-qPCR. In addition, downregulated expression of miR-520a-3p was associated with the clinical stage of the tumor and invasion in patients with GC. Furthermore, overexpression of miR-520a-3p significantly inhibited cell proliferation, invasion and migration in SGC-7901 and MGC-803 GC cell lines using proliferation, wound healing and cell invasion assays. Spindle and kinetochore associated 2 (SKA2) was upregulated in GC cells using western blot analysis and a target gene of miR-520a-3p; miR-520a-3p mimics significantly reduced SKA2 expression. In addition, upregulation of SKA2 protein expression SKA2 reversed the miR-520a-3p-mediated inhibition of SGC-7901 cell proliferation, migration and invasion. In conclusion, miR-520a-3p functioned as a tumor suppressor gene by targeting SKA2 in GC cell lines, and may serve as a novel prognostic and potential therapeutic marker.
Keywords: gastric cancer; invasion; microRNA-520a-3p; migration; proliferation; spindle and kinetochore-associated protein 2.
Figures





Similar articles
-
Ropivacaine Inhibits the Growth, Migration and Invasion of Gastric Cancer Through Attenuation of WEE1 and PI3K/AKT Signaling via miR-520a-3p.Onco Targets Ther. 2020 Jun 9;13:5309-5321. doi: 10.2147/OTT.S244550. eCollection 2020. Onco Targets Ther. 2020. PMID: 32606749 Free PMC article.
-
The microRNA-520a-3p inhibits proliferation, apoptosis and metastasis by targeting MAP3K2 in non-small cell lung cancer.Am J Cancer Res. 2015 Jan 15;5(2):802-11. eCollection 2015. Am J Cancer Res. 2015. PMID: 25973317 Free PMC article.
-
MiR-520a-3p inhibits malignant progression of epithelial ovarian cancer by targeting SUV39H1 expression.Hum Cell. 2021 Mar;34(2):570-578. doi: 10.1007/s13577-020-00455-2. Epub 2020 Nov 16. Hum Cell. 2021. PMID: 33196969
-
Emerging role of miR-520a in human diseases.Pathol Res Pract. 2024 Oct;262:155545. doi: 10.1016/j.prp.2024.155545. Epub 2024 Aug 14. Pathol Res Pract. 2024. PMID: 39154603 Review.
-
SKA2/FAM33A: A novel gene implicated in cell cycle, tumorigenesis, and psychiatric disorders.Genes Dis. 2018 Nov 12;6(1):25-30. doi: 10.1016/j.gendis.2018.11.001. eCollection 2019 Mar. Genes Dis. 2018. PMID: 30906829 Free PMC article. Review.
Cited by
-
The Role of Dexmedetomidine in Tumor-Progressive Factors in the Perioperative Period and Cancer Recurrence: A Narrative Review.Drug Des Devel Ther. 2022 Jul 6;16:2161-2175. doi: 10.2147/DDDT.S358042. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35821701 Free PMC article. Review.
-
LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.Thorac Cancer. 2020 Mar;11(3):603-611. doi: 10.1111/1759-7714.13304. Epub 2020 Jan 17. Thorac Cancer. 2020. PMID: 31953899 Free PMC article.
-
Circ_0001387 regulates SKA2 to accelerate breast cancer progression through miR-136-5p.Thorac Cancer. 2023 Jun;14(18):1707-1718. doi: 10.1111/1759-7714.14916. Epub 2023 May 2. Thorac Cancer. 2023. PMID: 37132052 Free PMC article.
-
MicroRNA-937 is overexpressed and predicts poor prognosis in patients with colon cancer.Diagn Pathol. 2019 Dec 19;14(1):136. doi: 10.1186/s13000-019-0920-3. Diagn Pathol. 2019. PMID: 31856857 Free PMC article.
-
SKA1/2/3 is a prognostic and predictive biomarker in esophageal adenocarcinoma and squamous cell carcinoma.BMC Cancer. 2024 Nov 29;24(1):1480. doi: 10.1186/s12885-024-13257-8. BMC Cancer. 2024. PMID: 39614199 Free PMC article.
References
-
- Global Burden of Disease Cancer Collaboration. Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, et al. Global, regional and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3:524–548. doi: 10.1001/jamaoncol.2016.5688. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous